株式会社モダリス
Tokyo, JP · 5 known investors
Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.
Founders & leadership
HM
Haruhiko Morita代表取締役CEO (President & CEO)
Investors · 5
Competitors · 4
by search overlap
Trisaluslifesci9 shared keywordsTriSalus develops a therapeutic platform combining its Pressure-Enabled Drug Delivery (PEDD) method with immune-activating therapies to overcome intratumoral pressure and immunosuppression that limit treatment of liver and pancreatic tumors. The platform is designed to be used alongside systemic immunotherapies such as checkpoint inhibitors for cancer patients.
Gradalis8 shared keywordsGradalis develops Vigil, a patient-specific immunotherapy studied in research and clinical trials for treating ovarian cancer, with potential use in other solid tumors. The therapy can be used on its own or alongside other cancer treatments.
Chrysalis Biotherapeutics7 shared keywordsChrysalis Biotherapeutics is a clinical-stage biopharmaceutical company developing peptide therapeutics, led by its drug candidate TP508 (Rusalatide acetate, Chrysalin), which activates endothelial and stem cells to repair tissue after severe viral infection or nuclear radiation. Its immediate target is treating mild to moderate acute respiratory distress syndrome (ARDS) to reduce mortality.
Bioworld7 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with 株式会社モダリス for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 株式会社モダリス do?
- Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.
- Who founded 株式会社モダリス?
- 株式会社モダリス was founded by Haruhiko Morita.
- Who are 株式会社モダリス's investors?
- 株式会社モダリス's investors include Medical Incubator Japan K.K., Nippon Venture Capital, Shinsei Capital Partners, SMBC Venture Capital, UTokyo Innovation Platform Co. Ltd..
- Where is 株式会社モダリス headquartered?
- 株式会社モダリス is headquartered in Tokyo, JP.